Published in J Virol on June 01, 2005
Targeted cell entry of lentiviral vectors. Mol Ther (2008) 2.34
Cytosolic 5'-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLoS One (2007) 2.18
Functional characterization of Negri bodies (NBs) in rabies virus-infected cells: Evidence that NBs are sites of viral transcription and replication. J Virol (2009) 1.43
Leader-Containing Uncapped Viral Transcript Activates RIG-I in Antiviral Stress Granules. PLoS Pathog (2016) 1.43
A vectored measles virus induces hepatitis B surface antigen antibodies while protecting macaques against measles virus challenge. J Virol (2007) 1.34
Measles virus circumvents the host interferon response by different actions of the C and V proteins. J Virol (2008) 1.32
Translational inhibition and increased interferon induction in cells infected with C protein-deficient measles virus. J Virol (2006) 1.28
Interplay between innate immunity and negative-strand RNA viruses: towards a rational model. Microbiol Mol Biol Rev (2011) 1.22
Model-based design of growth-attenuated viruses. PLoS Comput Biol (2006) 1.15
Region between the canine distemper virus M and F genes modulates virulence by controlling fusion protein expression. J Virol (2008) 1.07
Rational attenuation of a morbillivirus by modulating the activity of the RNA-dependent RNA polymerase. J Virol (2005) 1.01
Inhibition of ubiquitination and stabilization of human ubiquitin E3 ligase PIRH2 by measles virus phosphoprotein. J Virol (2005) 0.99
Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus. J Virol (2008) 0.98
In vivo ligands of MDA5 and RIG-I in measles virus-infected cells. PLoS Pathog (2014) 0.97
Measles viruses possessing the polymerase protein genes of the Edmonston vaccine strain exhibit attenuated gene expression and growth in cultured cells and SLAM knock-in mice. J Virol (2008) 0.96
Development of a challenge-protective vaccine concept by modification of the viral RNA-dependent RNA polymerase of canine distemper virus. J Virol (2007) 0.96
Suppression of the Sendai virus M protein through a novel short interfering RNA approach inhibits viral particle production but does not affect viral RNA synthesis. J Virol (2006) 0.94
De novo synthesis of N and P proteins as a key step in Sendai virus gene expression. J Virol (2007) 0.91
Sustained autophagy contributes to measles virus infectivity. PLoS Pathog (2013) 0.90
Plasticity in structural and functional interactions between the phosphoprotein and nucleoprotein of measles virus. J Biol Chem (2012) 0.88
Initiation and regulation of paramyxovirus transcription and replication. Virology (2015) 0.87
Fatal measles virus infection prevented by brain-penetrant fusion inhibitors. J Virol (2013) 0.87
Reinitiated viral RNA-dependent RNA polymerase resumes replication at a reduced rate. Nucleic Acids Res (2008) 0.86
Mumps virus Enders strain is sensitive to interferon (IFN) despite encoding a functional IFN antagonist. J Gen Virol (2009) 0.86
Elements in the canine distemper virus M 3' UTR contribute to control of replication efficiency and virulence. PLoS One (2012) 0.84
Sequence of events in measles virus replication: role of phosphoprotein-nucleocapsid interactions. J Virol (2014) 0.82
Phosphorylation of measles virus nucleoprotein affects viral growth by changing gene expression and genomic RNA stability. J Virol (2013) 0.81
Comparative analysis of viral RNA signatures on different RIG-I-like receptors. Elife (2016) 0.80
Quantitative estimation of Nipah virus replication kinetics in vitro. Virol J (2006) 0.80
HSP90 Chaperoning in Addition to Phosphoprotein Required for Folding but Not for Supporting Enzymatic Activities of Measles and Nipah Virus L Polymerases. J Virol (2016) 0.78
Interaction between the C-terminal domains of measles virus nucleoprotein and phosphoprotein: a tight complex implying one binding site. Protein Sci (2012) 0.77
Establishment of an in vitro transcription system for Peste des petits ruminant virus. Virol J (2012) 0.76
Newly identified minor phosphorylation site threonine-279 of measles virus nucleoprotein is a prerequisite for nucleocapsid formation. J Virol (2013) 0.76
Host-Pathogen Interactions in Measles Virus Replication and Anti-Viral Immunity. Viruses (2016) 0.75
Evaluation of nucleocapsid and phosphoprotein p functionality as critical factors during the early phase of paramyxoviral infection. Open Virol J (2012) 0.75
Modulation of Re-initiation of Measles Virus Transcription at Intergenic Regions by PXD to NTAIL Binding Strength. PLoS Pathog (2016) 0.75
Development of strand-specific real-time RT-PCR to distinguish viral RNAs during Newcastle disease virus infection. ScientificWorldJournal (2014) 0.75
The structurally disordered paramyxovirus nucleocapsid protein tail domain is a regulator of the mRNA transcription gradient. Sci Adv (2017) 0.75
Organization, Function, and Therapeutic Targeting of the Morbillivirus RNA-Dependent RNA Polymerase Complex. Viruses (2016) 0.75
Nipah and Hendra Virus Nucleoproteins Inhibit Nuclear Accumulation of STAT1 and STAT2 by Interfering with Their Complex Formation. J Virol (2017) 0.75
Rescue of measles viruses from cloned DNA. EMBO J (1995) 7.87
Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol (1993) 7.27
The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J Virol (1993) 6.38
Localized attenuation and discontinuous synthesis during vesicular stomatitis virus transcription. Cell (1981) 5.38
Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro. J Virol (1992) 2.73
Altered transcription of a defective measles virus genome derived from a diseased human brain. EMBO J (1987) 2.67
Error catastrophe and antiviral strategy. Proc Natl Acad Sci U S A (2002) 2.10
Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses. BMC Microbiol (2001) 1.89
Measles virus phosphoprotein retains the nucleocapsid protein in the cytoplasm. Virology (1991) 1.77
Two RNA polymerase complexes from vesicular stomatitis virus-infected cells that carry out transcription and replication of genome RNA. Proc Natl Acad Sci U S A (2004) 1.74
Viral replication and development of specific immunity in macaques after infection with different measles virus strains. J Infect Dis (1994) 1.65
Expression of measles virus V protein is associated with pathogenicity and control of viral RNA synthesis. J Virol (1998) 1.63
Polyploid measles virus with hexameric genome length. EMBO J (2002) 1.55
Modulating the function of the measles virus RNA-dependent RNA polymerase by insertion of green fluorescent protein into the open reading frame. J Virol (2002) 1.51
Transcriptional control of the RNA-dependent RNA polymerase of vesicular stomatitis virus. Biochim Biophys Acta (2002) 1.49
Genetic recombination during coinfection of two mutants of human respiratory syncytial virus. J Virol (2003) 1.44
The Sendai virus V protein interacts with the NP protein to regulate viral genome RNA replication. Virology (1996) 1.40
Transcribing of Escherichia coli genes with mutant T7 RNA polymerases: stability of lacZ mRNA inversely correlates with polymerase speed. Proc Natl Acad Sci U S A (1995) 1.36
Structure, transcription, and replication of measles virus. Curr Top Microbiol Immunol (1995) 1.35
Conformational flexibility in recombinant measles virus nucleocapsids visualised by cryo-negative stain electron microscopy and real-space helical reconstruction. J Mol Biol (2004) 1.35
Measles virus: conditions for the propagation and purification of infectious virus in high yield. J Virol Methods (1984) 1.35
Viral DNA polymerase scanning and the gymnastics of Sendai virus RNA synthesis. Virology (2004) 1.33
Mutations in the measles virus C protein that up regulate viral RNA synthesis. Virology (2001) 1.27
Sendai virus gene expression in lytically and persistently infected cells. Virology (1990) 1.24
Reexamination of the Sendai virus P protein domains required for RNA synthesis: a possible supplemental role for the P protein. Virology (1996) 1.23
Measles virus synthesizes both leaderless and leader-containing polyadenylated RNAs in vivo. J Virol (1989) 1.22
Sendai virus genome synthesis and assembly are coupled: a possible mechanism to promote viral RNA polymerase processivity. J Gen Virol (2001) 1.17
The assembly of the measles virus nucleoprotein into nucleocapsid-like particles is modulated by the phosphoprotein. Virology (1997) 1.15
Localization of P, NP, and M proteins on Sendai virus nucleocapsid using immunogold labeling. Virology (1986) 1.11
Replication and assembly of VSV nucleocapsids: protein association with RNPs and the effects of cycloheximide on replication. Virology (1980) 1.09
Restriction of measles virus RNA synthesis by a mouse host cell line: trans-complementation by polymerase components or a human cellular factor(s). J Virol (2002) 0.98
Chemical modification of nucleotide bases and mRNA editing depend on hexamer or nucleoprotein phase in Sendai virus nucleocapsids. RNA (2002) 0.98
Intracellular metabolism of sendai virus nucleocapside. Virology (1978) 0.95
Generation and characterization of P gene-deficient rabies virus. Virology (2004) 0.92
HEMCAM/CD146 downregulates cell surface expression of beta1 integrins. J Cell Sci (2001) 0.90
Circular and elongated linear forms of measles virus nucleocapsid. Nature (1976) 0.89
Selective inhibition of translation of the mRNA coding for measles virus membrane protein at elevated temperatures. J Virol (1987) 0.88
Establishment of Sendai virus persistent infection: biochemical analysis of the early phase of a standard plus defective interfering virus infection of BHK cells. Virology (1981) 0.85
The effect of cycloheximide on the replication of measles virus. J Gen Virol (1977) 0.84
Localization of P protein binding sites on the Sendai virus nucleocapsid. J Gen Virol (1990) 0.83
Replication of measles virus: continued synthesis of nucleocapsid RNA and increased synthesis of mRNA in the presence of cycloheximide. J Virol (1974) 0.82
Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell (2011) 4.11
Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat Immunol (2007) 4.09
Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol (2002) 2.86
Virus entry, assembly, budding, and membrane rafts. Microbiol Mol Biol Rev (2003) 2.68
Cytosolic 5'-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response. PLoS One (2007) 2.18
Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog (2007) 2.09
Strength of envelope protein interaction modulates cytopathicity of measles virus. J Virol (2002) 1.97
Early target cells of measles virus after aerosol infection of non-human primates. PLoS Pathog (2011) 1.80
A physical and functional link between cholesterol and tetraspanins. Eur J Immunol (2003) 1.54
In vivo tropism of attenuated and pathogenic measles virus expressing green fluorescent protein in macaques. J Virol (2010) 1.35
Multiple levels of interactions within the tetraspanin web. Biochem Biophys Res Commun (2003) 1.34
Molecular mechanisms of measles virus persistence. Virus Res (2005) 1.32
Analysis of receptor (CD46, CD150) usage by measles virus. J Gen Virol (2002) 1.23
Morbilliviruses and human disease. J Pathol (2006) 1.22
Human C3 deficiency associated with impairments in dendritic cell differentiation, memory B cells, and regulatory T cells. J Immunol (2008) 1.20
Measles immune suppression: lessons from the macaque model. PLoS Pathog (2012) 1.18
Recent mumps outbreaks in vaccinated populations: no evidence of immune escape. J Virol (2011) 1.18
Optimized SYBR green real-time PCR assay to quantify the absolute copy number of measles virus RNAs using gene specific primers. J Virol Methods (2005) 1.18
Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus. Mol Cell Proteomics (2010) 1.14
Ligand binding determines whether CD46 is internalized by clathrin-coated pits or macropinocytosis. J Biol Chem (2003) 1.10
Wild-type measles virus infection of primary epithelial cells occurs via the basolateral surface without syncytium formation or release of infectious virus. J Gen Virol (2009) 1.10
The pathogenesis of measles. Curr Opin Virol (2012) 1.09
Measles virus M and F proteins associate with detergent-resistant membrane fractions and promote formation of virus-like particles. J Gen Virol (2007) 1.06
Nipah virus uses leukocytes for efficient dissemination within a host. J Virol (2011) 1.05
Rapid titration of measles and other viruses: optimization with determination of replication cycle length. PLoS One (2011) 1.04
Rinderpest eradication: lessons for measles eradication? Curr Opin Virol (2012) 1.01
Rational attenuation of a morbillivirus by modulating the activity of the RNA-dependent RNA polymerase. J Virol (2005) 1.01
The F gene of rodent brain-adapted mumps virus is a major determinant of neurovirulence. J Virol (2007) 0.99
Inhibition of ubiquitination and stabilization of human ubiquitin E3 ligase PIRH2 by measles virus phosphoprotein. J Virol (2005) 0.99
Restriction of measles virus RNA synthesis by a mouse host cell line: trans-complementation by polymerase components or a human cellular factor(s). J Virol (2002) 0.98
Molecular biology, pathogenesis and pathology of mumps virus. J Pathol (2015) 0.95
Viral hijacking of cellular ubiquitination pathways as an anti-innate immunity strategy. Viral Immunol (2006) 0.94
Foot-and-mouth disease virus, but not bovine enterovirus, targets the host cell cytoskeleton via the nonstructural protein 3Cpro. J Virol (2008) 0.93
Cell surface activation of the alternative complement pathway by the fusion protein of measles virus. J Gen Virol (2004) 0.92
A point mutation, E95D, in the mumps virus V protein disengages STAT3 targeting from STAT1 targeting. J Virol (2009) 0.90
Measles virus infection of epithelial cells in the macaque upper respiratory tract is mediated by subepithelial immune cells. J Virol (2013) 0.90
BRCA1 interacts with and is required for paclitaxel-induced activation of mitogen-activated protein kinase kinase kinase 3. Cancer Res (2004) 0.89
Refined study of the interaction between HIV-1 p6 late domain and ALIX. Retrovirology (2008) 0.89
Plasticity in structural and functional interactions between the phosphoprotein and nucleoprotein of measles virus. J Biol Chem (2012) 0.88
Molecular differences between two Jeryl Lynn mumps virus vaccine component strains, JL5 and JL2. J Gen Virol (2009) 0.87
Chronic Infection of Domestic Cats with Feline Morbillivirus, United States. Emerg Infect Dis (2016) 0.85
A prominent role for DC-SIGN+ dendritic cells in initiation and dissemination of measles virus infection in non-human primates. PLoS One (2012) 0.85
Evaluation of synthetic infection-enhancing lipopeptides as adjuvants for a live-attenuated canine distemper virus vaccine administered intra-nasally to ferrets. Vaccine (2012) 0.85
Measles vaccination of nonhuman primates provides partial protection against infection with canine distemper virus. J Virol (2014) 0.85
Gene-specific contributions to mumps virus neurovirulence and neuroattenuation. J Virol (2011) 0.83
Measles virus minigenomes encoding two autofluorescent proteins reveal cell-to-cell variation in reporter expression dependent on viral sequences between the transcription units. J Gen Virol (2007) 0.83
Measles virus superinfection immunity and receptor redistribution in persistently infected NT2 cells. J Gen Virol (2005) 0.82
Infection of lymphoid tissues in the macaque upper respiratory tract contributes to the emergence of transmissible measles virus. J Gen Virol (2013) 0.81
Determination of spontaneous mutation frequencies in measles virus under nonselective conditions. J Virol (2012) 0.81
Paramyxovirus infections in ex vivo lung slice cultures of different host species. J Virol Methods (2013) 0.81
Pathological consequences of systemic measles virus infection. J Pathol (2015) 0.81
Cellular receptors, differentiation and endocytosis requirements are key factors for type I IFN response by human epithelial, conventional and plasmacytoid dendritic infected cells by measles virus. Virus Res (2010) 0.80
Selection of single-chain antibodies that specifically interact with vesicular stomatitis virus (VSV) nucleocapsid and inhibit viral RNA synthesis. J Virol Methods (2005) 0.79
Presence of lysine at aa 335 of the hemagglutinin-neuraminidase protein of mumps virus vaccine strain Urabe AM9 is not a requirement for neurovirulence. Vaccine (2009) 0.79
Structure of the measles virus H glycoprotein sheds light on an efficient vaccine. Proc Natl Acad Sci U S A (2007) 0.79
The interaction between the measles virus nucleoprotein and the Interferon Regulator Factor 3 relies on a specific cellular environment. Virol J (2009) 0.78
High-density rafts preferentially host the complement activator measles virus F glycoprotein but not the regulators of complement activation. Mol Immunol (2008) 0.78
New concepts in measles virus replication: getting in and out in vivo and modulating the host cell environment. Virus Res (2011) 0.77
A CD46CD[55-46] chimeric receptor, eight short consensus repeats long, acts as an inhibitor of both CD46 (MCP)- and CD150 (SLAM)-mediated cell-cell fusion induced by CD46-using measles virus. J Gen Virol (2002) 0.77
Dissecting partner recognition by an intrinsically disordered protein using descriptive random mutagenesis. J Mol Biol (2013) 0.77
Mutation of the TYTLE motif in the cytoplasmic tail of the sendai virus fusion protein deeply affects viral assembly and particle production. PLoS One (2013) 0.77
Heparan sulfate-dependent enhancement of henipavirus infection. MBio (2015) 0.76
Infection of human oligodendroglioma cells by a recombinant measles virus expressing enhanced green fluorescent protein. J Neurovirol (2002) 0.75
[RIG-I: a viral RNA detector molecular switch]. Med Sci (Paris) (2012) 0.75
Live-cell visualization of transmembrane protein oligomerization and membrane fusion using two-fragment haptoEGFP methodology. Biosci Rep (2012) 0.75